- Home
- KGEI vs TKNO Comparison
KGEI vs TKNO Comparison
Compare KGEI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGEI
- TKNO
- Stock Information
- Founded
- KGEI 2008
- TKNO 1996
- Country
- KGEI United States
- TKNO United States
- Employees
- KGEI N/A
- TKNO N/A
- Industry
- KGEI
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- KGEI
- TKNO Health Care
- Exchange
- KGEI Nasdaq
- TKNO Nasdaq
- Market Cap
- KGEI 254.9M
- TKNO 256.9M
- IPO Year
- KGEI N/A
- TKNO 2021
- Fundamental
- Price
- KGEI $5.92
- TKNO $4.42
- Analyst Decision
- KGEI Strong Buy
- TKNO
- Analyst Count
- KGEI 1
- TKNO 0
- Target Price
- KGEI $11.00
- TKNO N/A
- AVG Volume (30 Days)
- KGEI 78.9K
- TKNO 160.6K
- Earning Date
- KGEI 11-11-2025
- TKNO 11-06-2025
- Dividend Yield
- KGEI N/A
- TKNO N/A
- EPS Growth
- KGEI 35.27
- TKNO N/A
- EPS
- KGEI 0.54
- TKNO N/A
- Revenue
- KGEI $57,936,000.00
- TKNO $38,923,000.00
- Revenue This Year
- KGEI $14.07
- TKNO $9.52
- Revenue Next Year
- KGEI $26.69
- TKNO $15.20
- P/E Ratio
- KGEI $10.59
- TKNO N/A
- Revenue Growth
- KGEI 6.52
- TKNO 11.40
- 52 Week Low
- KGEI $2.91
- TKNO $3.94
- 52 Week High
- KGEI $9.89
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- KGEI 59.48
- TKNO 49.11
- Support Level
- KGEI $5.03
- TKNO $3.94
- Resistance Level
- KGEI $5.45
- TKNO $4.72
- Average True Range (ATR)
- KGEI 0.20
- TKNO 0.29
- MACD
- KGEI 0.08
- TKNO 0.04
- Stochastic Oscillator
- KGEI 72.73
- TKNO 61.94
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.